Immunosurveillance function of human mast cell? [1]

World Journal of Gastroenterology

Volumn 11, Issue 44, 2005, Pages 7054-7056

  Özdemir, Öner ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytotoxicity; Immunosurveillance; Mast cell; Tryptasechymase; Tumors

Indexed keywords

CHYMASE; SERINE PROTEINASE; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANTIGEN PRESENTATION; APOPTOSIS; CELL DENSITY; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; HUMAN; IMMUNOSURVEILLANCE; LETTER; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; TUMOR LOCALIZATION;

EID: 31144439539     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i44.7054     Document Type: Letter

References (26)

1. Tan SY, Fan Y, Luo HS, Shen ZX, Guo Y, Zhao LJ. Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol 2005; 11: 1210-1214
2. Özdemir Ö, Ravindranath Y, Savasan S. Evaluation of long-term liquid culture grown human bone marrow mast cell cytotoxicity against human leukemia cells. Blood 2002; 100, 45b, abstract # 3642
3. Özdemir Ö, Moore C, Ravindranath Y, Savasan S. Can Mast Cells Mediate Natural Cytotoxicity in Short Term Culture? Ann Allergy Asthma Immunol 2004; 94: 185, abstract # 216
4. Özdemir Ö, Ravindranath Y, Savasan S. Short Term Mast Cell Natural Cell-Mediated Cytotoxicity. Ann Allergy Asthma Immunol 2004; 94: 186-187, abstract # 220
5. Aaltomaa S, Lipponen P, Papinaho S, Kosma VM. Mast cells in breast cancer. Anticancer Res 1993; 13: 785-788
6. Ueda T, Aozasa K, Tsujimoto M, Yoshikawa H, Kato T, Ono K, Matsumoto K. Prognostic significance of mast cells in soft tissue sarcoma. Cancer 1988; 62: 2416-2419
7. Grimbaldeston MA, Skov L, Baadsgaard O, Skov BG, Marshman G, Finlay-Jones JJ, Hart PH. Communications: high dermal mast cell prevalence is a predisposing factor for basal cell carcinoma in humans. J Invest Dermatol 2000; 115: 317-320
8. Roche WR. The nature and significance of tumour-associated mast cells. J Pathol 1986; 148: 175-182
9. Özdemir Ö, Savaşan S. The role of mast cells in bone marrow diseases. J Clin Path 2004; 57: 108-109
10. Ghiara P, Boraschi D, Villa L, Scapigliati G, Taddei C, Tagliabue A. In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology 1985; 55: 317-324
11. Kataoka TR, Morii E, Oboki K, Kitamura Y. Strain-dependent inhibitory effect of mutant mi-MITF on cytotoxic activities of cultured mast cells and natural killer cells of mice. Lab Invest 2004; 84: 376-384
12. Wagelie-Steffen AL, Hartmann K, Vliagoftis H, Metcalfe DD. Fas ligand (FasL, CD95L, APO-1L) expression in murine mast cells. Immunology 1998; 94: 569-574
13. Leskinen MJ, Lindstedt KA, Wang Y, Kovanen PT. Mast cell chymase induces smooth muscle cell apoptosis by a mechanism involving fibronectin degradation and disruption of focal adhesions. Arterioscler Thromb Vasc Biol 2003; 23: 238-243
14. Terada T, Matsunaga Y. Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Hepatol 2000; 33: 961-966
15. Kankkunen JP, Harvima IT, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer 1997; 72: 385-388
16. Cabanillas-Saez A, Schalper JA, Nicovani SM, Rudolph MI. Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int J Gynecol Cancer 2002; 12: 92-98
17. Benitez-Bribiesca L, Wong A, Utrera D, Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 2001; 49: 1061-1062
18. de Rey BM, Palmieri MA, Duran HA. Mast cell phenotypic changes in skin of mice during benzoyl peroxide-induced tumor promotion. Tumour Biol 1994; 15: 166-174
19. Yang M, Zhang X, He A. [Mast cells in the labial cancer: histochemical and electron microscopical study] Zhonghua Kouqiang Yixue Zazhi 1997; 32: 13-15
20. Nagata M, Shijubo N, Walls AF, Ichimiya S, Abe S, Sato N. Chymase-positive mast cells in small sized adenocarcinoma of the lung. Virchows Arch 2003; 443: 565-573
21. Beil WJ, Fureder W, Wiener H, Grossschmidt K, Maier U, Schedle A, Bankl HC, Lechner K, Valent P. Phenotypic and functional characterization of mast cells derived from renal tumor tissues. Exp Hematol 1998; 26: 158-169
22. Gulubova MV. Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers. Clin Exp Metastasis 2003; 20: 611-620
23. Rojas IG, Spencer ML, Martinez A, Maurelia MA, Rudolph MI. Characterization of mast cell subpopulations in lip cancer. J Oral Pathol Med 2005; 34: 268-273
24. Welle M. Development, significance, and heterogeneity of mast cells with particular regard to the mast cell-specific proteases chymase and tryptase. J Leukoc Biol 1997; 61: 233-245
25. Ribatti D, Vacca A, Marzullo A, Nico B, Ria R, Roncali L, Dammacco F. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 2000; 85: 171-175
26. Theoharides TC, Conti P. Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 2004; 25: 235-241